Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives

Clinical evidence suggests that nebulized colistimethate sodium (CMS) has benefits for treating lower respiratory tract infections caused by multidrug-resistant Gram-negative bacteria (GNB). Colistin is positively charged, while CMS is negatively charged, and both have a high molecular mass and are...

Полное описание

Библиографические подробности

Главные авторы:	Yinggang Zhu, Antoine Monsel, Jason A. Roberts, Konstantinos Pontikis, Olivier Mimoz, Jordi Rello, Jieming Qu, Jean-Jacques Rouby, on behalf of the European Investigator Network for Nebulized Antibiotics in Ventilator-Associated Pneumonia (ENAVAP)
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2021-05-01
Серии:	Microorganisms
Предметы:	nebulized polymyxin nebulized colistimethate sodium colistin multidrug resistant gram-negative bacteria ventilator-associated pneumonia ventilator-associated tracheobronchitis
Online-ссылка:	https://www.mdpi.com/2076-2607/9/6/1154
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!